Content area

|
|

Statens investering i kliniske forsøg

Forfattere
Sofie Louise Rygård, Maj-Brit Nørregaard Kjær & Anders Perner Intensiv Terapiklinik, Rigshospitalet Ugeskr Læger 2018;180:V09170645
Reference: 
Ugeskr Læger 2018;180:V09170645
Sidetal: 
2-4
Danish public research investments in clinical trials
Clinical trials are important to ensure that patients and society benefit from healthcare interventions. Among the Danish public research investments in medical sciences the main part of funding is given to preclinical and translational research, and less than ten per cent is given to clinical trials. This imbalance may have negative consequences for patients and society, because public investment in clinical trials is likely to ensure broader availability of tested interventions independent of diseases, patient groups, caregivers and clinical settings.

💬 0 Kommentarer

Du skal være logget ind for at læse denne artikel
Log ind

Right side

af Christian Frøkjær Thomsen | 16/07
1 Kommentar
af Tine Bodil Houmann | 15/07
37 kommentarer
af Klaus Roelsgaard | 15/07
2 kommentarer
af Geske Johanne Glahn | 14/07
1 Kommentar
af Finn Redke | 14/07
4 kommentarer
af Finn Redke | 14/07
3 kommentarer